40 IU Intranasal Oxytocin for Borderline Personality Disorder
This study is suspended in the United States. It is testing 40 IU Intranasal Oxytocin for Borderline Personality Disorder.
Personality disorders, Borderline personalityDrugFrom 18 Years to 55 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
In plain English
Key information made simple
What is this study testing?
This study is testing whether 40 IU Intranasal Oxytocin may be useful for adults experiencing personality disorders.
What would participation involve?
Participants may receive 40 IU Intranasal Oxytocin, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in the United States.
Who is it mainly for?
This study appears to be mainly for adults with personality disorders.
What should you check before joining?
Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.
Your next step
Check the study details
Check the official source, then confirm these points with the research team.
Where are visits, can any be remote, and how much time is needed?
Costs and support
What costs, reimbursement or compensation apply?
Before joining
Questions to ask before joining
What are the exact eligibility criteria, and what could exclude someone?
How many visits, assessments, or follow-ups are expected, and over what period?
What risks, side effects, practical burdens, or alternatives should be understood first?
Who should be contacted to confirm locations, timing, compensation, and next steps?
Study clarity
Things to check before joining
Study start dateStarted: August 26, 2014
Recruitment status
Suspended
Enrollment listed in the registry
40
Sponsor
Icahn School of Medicine at Mount Sinai
Sponsor type
University
Study type
Drug
Intervention type
Medication / drug
Study phase
Not clearly listed
Locations
United States
Age range
From 18 Years to 55 Years
Official registry ID
NCT02225600
Official title
The Effect of Oxytocin Administration on Interpersonal Cooperation in Borderline Personality Disorder Patients and Healthy Adults: A Pilot Behavioral Study
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT02225600. We help you review the study, but cannot decide medical eligibility.
Recruitment & locations
Suspended
New York
Registry details
Registry conditions (original wording)
Borderline Personality Disorder
FAQ
Questions about this study
Who is behind this study?
The study sponsor is Icahn School of Medicine at Mount Sinai, a university.
Does this study involve medication?
Yes. The study involves medication, including 40 IU Intranasal Oxytocin, Placebo and 24 IU intranasal Oxytocin.
Who can participate?
Listed age limits: 18 years to 55 years.
Is this study still recruiting?
The registry lists this study as suspended.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
